There are 286 resources available
Introduction
Presenter: Enrico Franceschi
Session: State-of-the-art diagnosis and management of rare primary CNS tumours
Resources:
Webcast
42O - A phase Ia/b, dose-escalation and expansion study evaluating the MDM2–p53 antagonist BI 907828 in patients with solid tumours: Safety and efficacy in patients with dedifferentiated liposarcoma (DDLPS)
Presenter: Patrick Schoeffski
Session: Proffered paper session – Sarcoma
Resources:
Abstract
Slides
Webcast
Overview of neoadjuvant chemotherapy
Presenter: Javier Martin-Broto
Session: STS2: Neoadjuvant and adjuvant chemotherapy
Resources:
Slides
Webcast
43O - MDM2 inhibitor milademetan: Safety profile and management of adverse events (AEs)
Presenter: Chiara Fabbroni
Session: Proffered paper session – Sarcoma
Resources:
Abstract
Slides
Webcast
Positioning of adjuvant chemotherapy in current practice
Presenter: Bernd Kasper
Session: STS2: Neoadjuvant and adjuvant chemotherapy
Resources:
Slides
Webcast
Medulloblastoma
Presenter: Enrico Franceschi
Session: State-of-the-art diagnosis and management of rare primary CNS tumours
Resources:
Slides
Webcast
44O - Comparison of clinical outcomes of patients with infantile fibrosarcoma (IFS) treated with larotrectinib in the SCOUT study versus historical cohort: The EPI-VITRAKVI study
Presenter: Daniel Orbach
Session: Proffered paper session – Sarcoma
Resources:
Abstract
Slides
Webcast
What is the optimal perioperative sequence of chemotherapy and radiotherapy
Presenter: Antonia Digklia
Session: STS2: Neoadjuvant and adjuvant chemotherapy
Resources:
Slides
Webcast
Spinal cord tumours
Presenter: Elena Anghileri
Session: State-of-the-art diagnosis and management of rare primary CNS tumours
Resources:
Slides
Webcast
Invited discussant
Presenter: Jean-Yves Blay
Session: Proffered paper session – Sarcoma
Resources:
Slides
Webcast